Director/PDMR Shareholding
Summary by AI BETAClose X
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||||||||||||||||||||||||
|
a)
|
Name
|
1) Stephen Edward Foots 2) Stephen Richard Oxley 3) Mrs Sandra Elaine Breene 4) Thomas Michael Brophy 5) Anthony Damien Fitzpatrick 6) Michelle Angela Lydon 7) Thomas Herman Riermeier 8) Ritesh Tanna
|
|||||||||||||||||||||||||||
|
2
|
Reason for the notification
|
||||||||||||||||||||||||||||
|
a)
|
Position/status
|
1) Executive Director (PDMR) 2) Executive Director (PDMR) 3) Member of Executive Committee (PDMR) 4) Company Secretary (PDMR) 5) Member of Executive Committee (PDMR) 6) Member of Executive Committee (PDMR) 7) Member of Executive Committee (PDMR) 8) Member of Finance Committee (PDMR)
|
|||||||||||||||||||||||||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||||||||||||||||||||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||||||||||||||||||||||||
|
a)
|
Name
|
Croda International Plc |
|||||||||||||||||||||||||||
|
b)
|
LEI
|
2138004WCNBFJEEOXV26 |
|||||||||||||||||||||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||||||||||||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of 10.609756p each
ISIN: GB00BJFFLV09
|
|||||||||||||||||||||||||||
|
b)
|
Nature of the transaction
|
Purchase of shares under the Company's Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c) and shares purchased via dividend reinvestment on behalf of PDMRs detailed in c).
|
|||||||||||||||||||||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||||||||||||||||||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
|
|||||||||||||||||||||||||||
|
e)
|
Date of the transaction
|
2026-06-10 |
|||||||||||||||||||||||||||
|
f)
|
Place of the transaction
|
XLON |
|||||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 10 hours ago Johnson Matthey
- 11 hours ago Galliford Try
- 11 hours ago Galliford Try
- 11 hours ago Centrica
- 12 hours ago Smith & Nephew